BG-75098 / BeOne Medicines - LARVOL DELTA

A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=105 | Recruiting | Sponsor: BeOne Medicines | Trial completion date: Mar 2029 ➔ Nov 2028 | Trial primary completion date: Mar 2029 ➔ Nov 2028

Trial completion date • Trial primary completion date • Oncology • Solid Tumor • CDK2